SEER - Seer, Inc.
IEX Last Trade
2.215
0.455 20.542%
Share volume: 0
Last Updated: Tue 24 Dec 2024 06:20:15 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
19.80%
PREVIOUS CLOSE
CHG
CHG%
$1.76
0.46
25.85%
Fundamental analysis
20%
Profitability
0%
Dept financing
3%
Liquidity
75%
Performance
30%
Performance
5 Days
-4.33%
1 Month
-7.14%
3 Months
29.24%
6 Months
30.00%
1 Year
21.43%
2 Year
-60.88%
Key data
Stock price
$2.22
DAY RANGE
$1.76 - $2.24
52 WEEK RANGE
$1.58 - $2.62
52 WEEK CHANGE
$16.93
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: Omid C. Farokhzad
Region: US
Website: seer.bio
Employees: 160
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: seer.bio
Employees: 160
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Seer, Inc. engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software. The company intends to sell its products for research purposes.
Recent news